Michael Bruckman/LinkedIn
Dec 17, 2025, 05:54
Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
Michael Bruckman, CEO at Haima Therapeutics, shared on LinkedIn:
”Fantastic to see platelet-inspired nanoparticles gaining attention!
This work with Case Western Reserve University and Haima Therapeutics demonstrates how targeted drug delivery at sites of injury can dramatically improve outcomes; in this case, enhancing implanted electrode performance.
Excited about the broad potential of this platform, from neuroscience to trauma care and beyond.”
Read the full article here.
Article: Platelet-inspired nanoparticle delivers drugs directly where they are needed
Authors: Julia Rock-Torcivia
Stay updated on all scientific advances with Hemostasis Today.
-
May 10, 2026, 12:14Ana Cláudia de Souza: Presenting ÁRTEMIS-Brasil at ESOC 2026
-
May 10, 2026, 12:11Umberto Pensato: SPOTMAP Project and ESCAPE-MeVO Analysis Honored with Awards at ESOC 2026
-
May 10, 2026, 12:05Purusotham Chippala: A Comprehensive Patient and Caregiver Education Guide to Make Stroke Easier
-
May 10, 2026, 11:57Mostafa Meshref: Find Our Research Contributions at ESOC 2026
-
May 10, 2026, 11:39Ruisheng Su: Stroke Timer Is an Early Accept at MICCAI 2026
-
May 10, 2026, 11:24Ali Ahmadi: The Immune Landscape After Ischemic Stroke and How to Advance Toward Effective Therapeutic Strategies
-
May 10, 2026, 11:05Yusra Iqbal: The Clinical Spectrum of Platelet Disorders
-
May 10, 2026, 08:42Muhammad Asim: The Clinical Value of Cord Blood in Neonatal Practice
-
May 10, 2026, 08:22Annie Bauzon: Why Every MLS Should Understand Blood Products